|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Liver neoplasia and oral contraceptives. |
| NISSEN ED; NISSEN SE; KENT DR |
| Paper presented at the Program for Applied Research on Fertility Regulation |
| (PARFR) Workshop on Risks, Benefits, and Controversies in Fertility Control, |
| Arlington, Virginia, March 13-16, 1977. 21 p |
| 78 cases of benign hepatic neoplasia in young women exposed to oral contraceptives (OCs) are analyzed in an |
| attempt to assess the clinical and epidemiologic features of the syndrome. 78% of the patients were exposed to |
| mestranol-containing products for 80% of the total pill-months. Only 17% took ethinyl estradiol for 11% of the total pill- |
| months. Of 8 different progestogens available, 57% took norethindrone for 49% of pill-months. More than half the |
| patients took OCs for longer than 5 years. 85% were exposed for more than 4 years. The semantics involved in |
| describing this disease is a significant problem in reconciliation of case reports. It is believed, however, that nearly |
| all benign liver tumors in OC users are closely related to the prototypic lesion, the hepatic adenoma. The vascular |
| changes associated with this tumor represent the primary danger. Early diagnosis is difficult because of a lack of |
| good screening techniques. This problem is compounded by the symptom free condition of most patients until the |
| disease reaches advanced stages. The mechanism of pathogenesis is unknown. Various known effects of OC |
| steroids may play a role including cholestasis, hypercoagulation, vascualr wall thickening, and induction of the |
| hepatic intracellular enzyme system. A genetic deficiency in some women may prevent normal metabolism of |
| mestranol. (PubHealth.info Document ID: CONT7T 30-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Liver neoplasia and oral contraceptives.", is(are) NISSEN |
| ED; NISSEN SE; KENT DR. The source of this article is "Paper presented at the Program for Applied Research on |
| Fertility Regulation (PARFR) Workshop on Risks, Benefits, and Controversies in Fertility Control, Arlington, Virginia, |
| March 13-16, 1977. 21 p". This article was published in 1977 in English language(s). (PubHealth.info® Document |
| ID: CONT7T 30-06. All rights reserved with PubHealth.info) PIN: 30030 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
